Related to Tekmira Wins $34.7M Award to Develop RNAi Therapeutic against Ebola Virus

• Sorrento Wins Second NIAID Grant of $600K to Develop Qourum Quenching Antibacterial
  
• Fred Hutchinson Center Awarded $8.2M to Coordinate Obesity and Cancer Consortium
  
• Pharmacyclics Secures Five-Year CRADA with NCI to Develop Blood Cancer Drug
  
• $3M NIAID Grant Will Fund Inviragen Collaboration with UTMB to Develop Chikungunya Vaccine
  
• GeoVax Receives Latest Tranche of $19.6M NIAID Funding for HIV Vaccine
  
• AMRI Wins Five-Year $43M NIH Contract for Work Focused on CNS Diseases
  
• Trevena Scores $10M NIH Grant to Develop a Drug for Depression
  
• NHGRI Gives $1,000 Genome Project a $14M Shot in the Arm
  
• Muscular Dystrophy Association Makes $13.7M Available to 40 Research Programs
  
• Department of Defense Backs Two Lupus Projects with $2.3M
  
• NCI Awards $19.3M Grant to Study Breast Cancer Disparity Between African-American and European Women
  
• HemoShear Wins $4.3M NIH Grant to Develop Predictive Drug Database
  
• Selecta Wins SAIC Subcontract to Develop Synthetic Nanoparticle Malaria Vaccine
  
• GeoVax Labs Receives $0.8M Funding Boost from NIAID to Progress HIV Vaccine
  
• Theralpha Wins €2.55M in Funding to Take Snake Venom Analgesic into Early Clinical Trials
  
• Thermo Fisher Scientific Offers siRNA Reagent Libraries via Labcyte Echo® Qualified Plates
  
• Aura Raises $4.5M and Signs CRADA for Diagnostic and Therapeutic Nanoparticle Platform
  
• Diamyd Gets $3M to Develop Treatment for Chemotherapy-Induced Peripheral Neuropathy
  
• Aduro BioTech Wins $250K in SBIR Grants and Contract with UNM for Vaccine Development
  
• Investigators Get $8M to Set Up Parkinson’s Brain Bank